SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Frick Mats) "

Sökning: WFRF:(Frick Mats)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Costache, Mădălina Elena, et al. (författare)
  • Higher- And lower-order personality traits and cluster subtypes in social anxiety disorder
  • 2020
  • Ingår i: PLoS ONE. - Public Library of Science. - 1932-6203. ; 15:4
  • Tidskriftsartikel (refereegranskat)abstract
    • Social anxiety disorder (SAD) can come in different forms, presenting problems for diagnostic classification. Here, we examined personality traits in a large sample of patients (N = 265) diagnosed with SAD in comparison to healthy controls (N = 164) by use of the Revised NEO Personality Inventory (NEO-PI-R) and Karolinska Scales of Personality (KSP). In addition, we identified subtypes of SAD based on cluster analysis of the NEO-PI-R Big Five personality dimensions. Significant group differences in personality traits between patients and controls were noted on all Big Five dimensions except agreeableness. Group differences were further noted on most lower-order facets of NEO-PI-R, and nearly all KSP variables. A logistic regression analysis showed, however, that only neuroticism and extraversion remained significant independent predictors of patient/control group when controlling for the effects of the other Big Five dimensions. Also, only neuroticism and extraversion yielded large effect sizes when SAD patients were compared to Swedish normative data for the NEO-PI-R. A two-step cluster analysis resulted in three separate clusters labelled Prototypical (33%), Introvert-Conscientious (29%), and Instable-Open (38%) SAD. Individuals in the Prototypical cluster deviated most on the Big Five dimensions and they were at the most severe end in profile analyses of social anxiety, self-rated fear during public speaking, trait anxiety, and anxiety-related KSP variables. While additional studies are needed to determine if personality subtypes in SAD differ in etiological and treatment-related factors, the present results demonstrate considerable personality heterogeneity in socially anxious individuals, further underscoring that SAD is a multidimensional disorder.
2.
  • Hofmann, Robin, et al. (författare)
  • DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial.
  • 2014
  • Ingår i: American Heart Journal. - Mosby. - 1097-6744. ; 167:3, s. 322-328
  • Tidskriftsartikel (refereegranskat)abstract
    • The use of supplemental oxygen in the setting of suspected acute myocardial infarction (AMI) is recommended in international treatment guidelines and established in prehospital and hospital clinical routine throughout the world. However, to date there is no conclusive evidence from adequately designed and powered trials supporting this practice. Existing data are conflicting and fail to clarify the role of supplemental oxygen in AMI.
  •  
3.
  • Hofmann, Robin, et al. (författare)
  • Oxygen therapy in suspected acute myocardial infarction
  • 2017
  • Ingår i: New England Journal of Medicine. - Massachusetts Medical Society. - 0028-4793. ; 377:13, s. 1240-1249
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: The clinical effect of routine oxygen therapy in patients with suspected acute myocardial infarction who do not have hypoxemia at baseline is uncertain. METHODS: In this registry-based randomized clinical trial, we used nationwide Swedish registries for patient enrollment and data collection. Patients with suspected myocardial infarction and an oxygen saturation of 90% or higher were randomly assigned to receive either supplemental oxygen (6 liters per minute for 6 to 12 hours, delivered through an open face mask) or ambient air. RESULTS: A total of 6629 patients were enrolled. The median duration of oxygen therapy was 11.6 hours, and the median oxygen saturation at the end of the treatment period was 99% among patients assigned to oxygen and 97% among patients assigned to ambient air. Hypoxemia developed in 62 patients (1.9%) in the oxygen group, as compared with 254 patients (7.7%) in the ambient-air group. The median of the highest troponin level during hospitalization was 946.5 ng per liter in the oxygen group and 983.0 ng per liter in the ambient-air group. The primary end point of death from any cause within 1 year after randomization occurred in 5.0% of patients (166 of 3311) assigned to oxygen and in 5.1% of patients (168 of 3318) assigned to ambient air (hazard ratio, 0.97; 95% confidence interval [CI], 0.79 to 1.21; P=0.80). Rehospitalization with myocardial infarction within 1 year occurred in 126 patients (3.8%) assigned to oxygen and in 111 patients (3.3%) assigned to ambient air (hazard ratio, 1.13; 95% CI, 0.88 to 1.46; P=0.33). The results were consistent across all predefined subgroups. CONCLUSIONS: Routine use of supplemental oxygen in patients with suspected myocardial infarction who did not have hypoxemia was not found to reduce 1-year all-cause mortality. (Funded by the Swedish Heart–Lung Foundation and others; DETO2X-AMI ClinicalTrials.gov number, NCT01787110.)
  •  
4.
  • Johansson, Anna-Karin, et al. (författare)
  • Is one month treatment with dabigatran before cardioversion of atrial fibrillation sufficient to prevent thromboembolism?
  • 2015
  • Ingår i: Europace. - Oxford University Press. - 1532-2092. ; 17:10, s. 1514-1517
  • Tidskriftsartikel (refereegranskat)abstract
    • The use of direct oral anticoagulants (DOACs) in patients undergoing elective direct current (DC) cardioversion of non-acute atrial fibrillation (AF) can potentially shorten the time from initiation of anticoagulation treatment to cardioversion, compared with warfarin. The safety of this strategy needs to be investigated. Data from subgroup analysis from clinical trials with DOAC do not clarify whether 4-week treatment with DOAC is sufficient to prevent thromboembolism (TE) after cardioversion. The aim of this retrospective study was to assess the incidence of TE in anticoagulant naive patients converted after one month's pre-treatment with dabigatran.
  •  
5.
  • Nero, Daniella, et al. (författare)
  • Personality Traits in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries.
  • 2019
  • Ingår i: The American journal of medicine. - 1555-7162. ; 132:3, s. 374-381
  • Tidskriftsartikel (refereegranskat)abstract
    • The purpose of this study was to describe type A behavior pattern and trait anger in patients with myocardial infarction with nonobstructive coronary arteries (MINOCA) and compare them with patients with coronary heart disease and healthy controls. Type A behavior pattern and anger have been linked to coronary heart disease in previous studies. This is the first study to assess type A behavior pattern and trait anger in MINOCA patients.One hundred MINOCA patients, consecutively recruited during 2007-2011 at 5 coronary care units in Stockholm, were matched for sex and age to 100 coronary heart disease patients and 100 healthy controls. All participants completed the Bortner Rating Scale to quantify type A behavior pattern and the Spielberger Trait Anger Scale to quantify anger 3 months after the acute event.MINOCA patients' Bortner Rating Scale score was 70.9 ± 10.8 (mean ± SD) and Spielberger Trait Anger Scale score was 14 (12-17) (median; interquartile range). Coronary heart disease patients' Bortner Rating Scale score was 70.5 ± 10.2 and Spielberger Trait Anger Scale score was 14 (12-17). Healthy controls' Bortner Rating Scale score was 71.9 ± 9.1 and Spielberger Trait Anger Scale score was 13 (11-16).We found no significant differences in Bortner Rating Scale score and Spielberger Trait Anger Scale score among MINOCA, coronary heart disease patients, and healthy controls, regardless of whether total scores, subscales, or cutoffs were used to classify type A behavior pattern and trait anger. However, we cannot exclude the existence of an occasional episode of anger or mental stress in relation to the coronary event. This is the first study to assess type A behavior pattern and trait anger in patients with MINOCA, and future studies need to confirm the current findings before any firm conclusions can be made.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (18)
Typ av publikation
tidskriftsartikel (85)
konferensbidrag (14)
annan publikation (2)
doktorsavhandling (2)
Typ av innehåll
refereegranskat (84)
övrigt vetenskapligt (32)
Författare/redaktör
Fredrikson, Mats, (71)
Furmark, Tomas, (70)
Frick, Andreas, (69)
Engman, Jonas, (38)
Alaie, Iman, (29)
Björkstrand, Johanne ... (27)
visa fler...
Åhs, Fredrik, (26)
Gingnell, Malin, (25)
Wahlstedt, Kurt, (25)
Faria, Vanda, (24)
Larsson, Elna-Marie, (15)
Appel, Lieuwe, (14)
Jernberg, Tomas, (14)
Lubberink, Mark, (14)
Jonasson, My, (14)
Carlbring, Per, (11)
Andersson, Gerhard (11)
Linnman, Clas, (10)
Marteinsdottir, Ina (10)
Eriksson, Elias (8)
Wallenquist, Ulrika, (8)
Långström, Bengt, (7)
Tillfors, Maria (7)
Reis, Margareta, (7)
Björck, Lars, (7)
Antoni, Gunnar, (6)
Svensson, Leif (6)
Erlinge, David, (6)
von Knorring, Lars, (6)
Lindahl, Bertil, (6)
Hartvig, Per (6)
Ekelund, Ulf, (6)
Hofmann, Robin, (6)
Witt, Nils, (6)
Månsson, Kristoffer ... (6)
Van der Wee, Nic J. ... (5)
Eggers, Kai M., 1962 ... (5)
James, Stefan K, (5)
Lindahl, Bertil, 195 ... (5)
Tornvall, Per (5)
Howner , Katarina (5)
Bas-Hoogendam, Janna ... (5)
van Steenbergen, Hen ... (5)
Fouche, Jean-Paul (5)
Lochner, Christine (5)
Hattingh, Coenraad J ... (5)
Cremers, Henk R. (5)
Straube, Thomas (5)
Peterburs, Jutta (5)
Klumpp, Heide (5)
visa färre...
Lärosäte
Uppsala universitet (55)
Mittuniversitetet (12)
Lunds universitet (10)
Stockholms universitet (8)
Karolinska Institutet (7)
Linköpings universitet (6)
visa fler...
Göteborgs universitet (4)
Karlstads universitet (3)
Umeå universitet (2)
Högskolan i Borås (2)
Örebro universitet (1)
Linnéuniversitetet (1)
visa färre...
Språk
Engelska (98)
Svenska (1)
Odefinierat språk (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (65)
Samhällsvetenskap (47)
Naturvetenskap (4)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy